A positive correlation (r = 0.5716) was observed between CD163− tumor macrophages as a percentage of live cells in tumors and tumor volume; CD163+ macrophages were anticorrelated with tumor volume, but only as a percentage of CD45+ cells, suggesting modulation of resident macrophage production. Here, CD163 is linked to neoplasm.